key: cord-0275603-shvtbwrt
authors: Zou, Z.; Fairley, C. K.; Shen, M.; Scott, N.; Xu, X.; Li, Z.; Li, R.; Zhuang, G.; Zhang, L.
title: Critical timing for triggering public health interventions to prevent COVID-19 resurgence: a mathematical modelling study
date: 2021-07-07
journal: nan
DOI: 10.1101/2021.07.06.21260055
sha: 9a0fff9506733e2af789b948fcc4e15808cb45cc
doc_id: 275603
cord_uid: shvtbwrt

To prevent the catastrophic health and economic consequences from COVID-19 epidemics, some nations have aimed for no community transmission outside of quarantine. To achieve this, governments have had to respond rapidly to outbreaks with public health interventions. But the exact characteristics of an outbreak that trigger these measures differ and are poorly defined. We used existing data from epidemics in Australia to establish a practical model to assist stakeholders in making decisions about the optimal timing and extent of interventions. We found that the number of reported cases on the day that interventions commenced strongly predicted the size of the outbreaks. We quantified how effective interventions were at containing outbreaks in relation to the number of cases at the time the interventions commenced. We also found that containing epidemics from novel variants that had higher transmissibility would require more stringent interventions that commenced earlier. In contrast, increasing vaccination coverage would enable more relaxed interventions. Our model highlights the importance of early and decisive action in the early phase of an outbreak if governments aimed for zero community transmission, although new variants and vaccination coverage may change this.

To prevent the catastrophic health and economic consequences from COVID-19 epidemics, some 33 nations have aimed for no community transmission outside of quarantine. To achieve this, 34 governments have had to respond rapidly to outbreaks with public health interventions. But the 35 exact characteristics of an outbreak that trigger these measures differ and are poorly defined. We 36 used existing data from epidemics in Australia to establish a practical model to assist stakeholders 37 in making decisions about the optimal timing and extent of interventions. We found that the number 38 of reported cases on the day that interventions commenced strongly predicted the size of the 39 outbreaks. We quantified how effective interventions were at containing outbreaks in relation to the 40 number of cases at the time the interventions commenced. We also found that containing epidemics 41 from novel variants that had higher transmissibility would require more stringent interventions that 42 occasions, the state governments intervened when the number of daily cases was between 10-30 91 cases. The subsequent outbreak peak was substantial (<100 cases), and the outbreak was contained 92 within three months. On one occasion, intervening late at a daily reported case of 149 resulted in a 93 very high outbreak peak of 687 cases and an outbreak duration of almost five months (Table 1 , Fig.  94 1-2).

At a baseline scenario with contact tracing, voluntary testing, but no vaccination, we estimated the 97 effective reproduction number (R e ) of COVID-19 to be 1.88 (95% CI: 1.85-2.13) in Australia. We 98 observed that the interval between intervention commencement and reduction of R e to below one 99 was shortened with increasing experience in responding to the COVID-19 epidemic ( Table 1 , Fig.  100 1). In four recent outbreaks (after the second outbreak in Victoria), R e was reduced to near or below 101 one less than one week after the intervention commencement.

Surveillance for outbreak severity 104 showed three distinct regions that reflect various epidemic severities. Region A, where R e ≥1, 112

indicated an uncontrolled and expanding epidemic in the near future; Region B, where R e < 1 but 113 the predicted average daily cases over the next 7 days would still exceed a manageable level (e.g. 114 10 cases/day), indicated a controlled epidemic with a substantial risk of resurgence; Region C, where 115 R e < 1 and the predicted average daily cases over the next 7 days were <10 cases, indicated a 116 controlled epidemic with a reducing risk of resurgence.

Fig. 3b-j illustrated the trajectories of intervention change and the predicted outbreak severity for 119 the above nine outbreaks, from the date of intervention commencement to the date R e dropped to 120 one, to the date with a minimum R e , and to the date of easing intervention. We observed that on five 121 occasions, the trajectory of the projected epidemic severity underwent a shift from region A to region 122 B before moving to region C, suggesting a substantial risk of a larger and longer-lasting outbreak. 123

In contrast, on the remaining four occasions, the trajectory of the projected epidemic severity shifted 124 directly from region A to region C, suggesting a well-controlled outbreak. These were consistent 125 with the actual outbreak outcomes (Table 1 , Fig. 1-2 ). More importantly, the trajectories of 126 intervention change did not differ substantially across the nine occasions (all reduced R e below one), 127 and the number of cases on the day intervention commenced largely determined whether the 128 trajectory of epidemic severity would pass through region B. 129 130 mask use would reduce R e uniformly to one within 7 days. We found that in the baseline scenario, 135 to contain the epidemic to an average of ≤10 daily cases over the next 7 days, the critical number of 136 daily reported cases that should trigger interventions would be 6 cases.

If the transmissibility of the novel variants increased by 50%, 80%, 110%, and 140%, R e would be 140 increased to 2.75, 3.25, 3.73, and 4.20, respectively. Consistently, we observed a rising or even 141 vanishing threshold curve of R e (R e =1, Fig. 5 ). It indicated that more stringent combinations of social 142 distancing and face mask use, even in combinations with vaccination, would be required to reduce 143 R e below one. Further, the critical timing for intervention commencement would need to be 144 advanced as the transmissibility of the variants increases (Fig. 4) . With a 50% (estimated 40-80% 145 for the Alpha variant 12-14 ) increase in transmissibility and no vaccination, reducing social activity 146 by 80% of the pre-epidemic level combined with mandatory masks (50% coverage) could reduce 147 R e to one. The critical number of cases to trigger intervention commencement would be limited to 148 4 cases to maintain the average number of daily cases over the next 7 days to ≤10 cases ( Fig. 4-5) . 149

In contrast, with a 140% (estimated to be 60% higher for the Delta variant than for the Alpha 150 variant 15 ) increase in transmissibility, social distancing and face mask use alone would not be 151 sufficient to reduce R e below one. 152 153

If COVID-19 vaccination coverage reach 30%, 50%, 70% and 90% in a wildtype dominant 155 epidemic, R e would be significantly reduced to 1.43, 1.13, 0.82, and 0.51, respectively ( Our study identified the critical timing and extent for commencing public health interventions to 168 contain COVID-19 outbreaks in an Australian setting. We found that in the past outbreaks in four 169

Australian states, the number of reported cases on the day interventions commenced was a strong 170 predictor of the subsequent peak size of the outbreaks. We quantified the effective combinations of 171 interventions that would reduce R e below one and the critical number of daily cases for the 172 commencement of interventions. We indicated that in the early phase of an outbreak, containing the 173 prospective epidemic to a low level (≤10 cases/day) required effective interventions to be 174 commenced before the number of daily reported cases reaches 6 cases. However, an increase in viral 175 transmissibility would require stricter interventions to be commenced with a lower number of daily 176 cases. In contrast, increasing vaccination coverage would allow for less strict interventions and an 177 increase in the threshold for their commencement. 178 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 7, 2021.

Our study developed a practical model to assist decisions for determining the optimal timing and 180 extent of interventions from a stakeholders' perspective. To our best knowledge, this study is the 181 first of its kind to integrate existing public health interventions and epidemic severity to quantify 182 the risk of COVID-19 resurgence. It provides intuitive recommendations to stakeholders to take 183 early and decisive action. Our study also quantified the impact of various potential changes in viral Our study has several limitations. First, we simulated historical epidemics based on four Australian 214 states but excluding Queensland, which experienced a significant outbreak in March-April 2020. 215

That is because the state's official reports did not include information on whether a diagnosed case 216 is from a known or unknown source and hence cannot inform our model. Second, the rate of viral 217 transmission may vary across countries due to differences in health care capacities and the extent of 218 public health interventions. Our study uses Australia as a case study but intends to generalise this 219 work to other settings in future investigations. Similarly, we did not consider environmental 220 differences, which is likely to play a role and differ between states. Third, to the completion date of 221 this study, reliable data on the transmissibility and mortality of the novel variants of SARS-CoV-2 222 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 7, 2021. ; https://doi.org/10.1101/2021.07.06.21260055 doi: medRxiv preprint and the effectiveness of the COVID-19 vaccine against new variants are still under investigation. 223

Our study was conducted with limited availability of these data. Finally, we did not differentiate 224 between the nature of the new cases. Cases in the same household as a known case and those who 225 were isolated at the time of their diagnosis will be different from cases that are not linked to known 226 cases and who were not isolated at the time of their diagnosis. It was not possible to incorporate 227 these qualitative differences in a quantitative model, but they clearly matter.

In conclusion, our study quantified, for the first time, the extent of public health interventions that 230 would effectively control an outbreak and the critical timing for the commencement of interventions. 231

It provides stakeholders with intuitive recommendations to assist them in taking early and decisive 232 action and is, therefore, has important implications for facilitating the achievement of the ambitious 233 goal of rapid and complete control of the COVID-19 outbreak. Supplementary Information p4-5) . 255

The model assumed that approximately 17% of the infected individuals were asymptomatic and 256 never developed any noticeable symptoms 22 . Asymptomatic individuals would not be isolated but 257 later spontaneously recovered unless they were diagnosed due to voluntary testing or contact tracing. 258

The remaining 83% infected individuals would be 'pre-symptomatically infected' with an incubation 259 period (5.8 days on average) 23 , then later become symptomatic. Symptomatic individuals would be 260 diagnosed and isolated after an interval from symptom onset to isolation (4.2 days on average) 24 . 261

We assumed diagnosed individuals would die of COVID-19-related complications with a certain 262 probability. Transition probabilities in the model were shown in Supplementary Table 1 .

We simulated five public health interventions in the model, including contact tracing, social 266 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 7, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 7, 2021. for Alpha and 59.8% (28.9-77.3%) for Delta variant 35-37 . We, therefore, assumed a 2% and 10% 316 reduction in the efficacy of the vaccine against Alpha and Delta ( Supplementary Information p6,  317   11 ). 318 319

We calibrated the model by comparing the model-simulated epidemic indicators with the observed 321 data, including the number of daily reported cases, the number of daily known-source cases, the 322 number of daily unknown-source cases, and cumulative deaths in Victoria. We employed a 'genetic 323 algorithm' to search within the model parameters' initial ranges to determine the 'optimal' parameter 324 set based on the goodness-of-fit score and the likelihood ratio test 38, 39 . We performed about 325 1,000,000 simulations in total. We ranked the goodness-of-fit scores of the 'good-fitting sets' in Supplementary Information p11-13) . 332 333

When a COVID-19 case was diagnosed, contact-tracers would adopt a backwards-tracing strategy 335 to identify the source of transmission. A diagnosed case could be linked to the source of infection if 336

(1) the source was symptomatic and had been diagnosed, or (2) the source was pre-337 symptomatic/asymptomatic but had been diagnosed through voluntary testing, or (3) the source was 338 pre-symptomatic and was diagnosed due to the onset of symptoms during contact tracing. A 339 diagnosed individual could have an unknown source of infection only when the source was 340 asymptomatic and had not been detected by voluntary testing. With these assumptions, the actual 341 reported number of unknown-source cases might reflect the number of potentially asymptomatic 342

infections. In contrast, the number of known-source cases might reflect the number of pre-343 symptomatic/symptomatic infections in the population. The reasoning progress was graphically 344 depicted in Supplementary Fig. 7 .

To quantify the above relationships, we explored the association between reported daily locally 347 acquired cases and model-estimated potential undocumented infections using data from the second is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 7, 2021. ; https://doi.org/10.1101/2021.07.06.21260055 doi: medRxiv preprint regression, b = 13.32 [IQR: 12.9-14.14], p < 0.001). A significant linear relationship was found 355 between the number of daily known-source cases and the number of estimated active pre-356 symptomatic/symptomatic infections with a Pearson correlation coefficient of 0.92 (linear 357 regression, b = 13.13 [IQR: 12.96-13.9], p<0.001) ( Supplementary Fig. 8-9) . 358 359

Undocumented infections during outbreaks 362

Undocumented cases represented a potential risk of further community transmission of SARS-CoV-363 2. Three types of infections were considered 'undocumented' in our model. They were asymptomatic 364 infections, pre-symptomatic infections, and symptomatic infections before diagnosis 365 ( Supplementary Fig. 6 ).

Basic and effective reproduction number 368

The basic reproduction number (R 0 ) quantified the transmissibility of an infectious pathogen in its 369 initial phase. It was defined as the average number of secondary cases generated by a single 

We assessed the risk of the COVID-19 outbreak by predicting the number of secondary cases 380 potentially caused by undocumented cases over the next 7 days. In this setting, we assumed all 381 documented cases were well isolated and would not lead to further community transmission. We 382 estimated the number of secondary infections caused by the currently undocumented cases as 383 follows. First, we estimated R e under the influence of the current public health interventions (Fig.  384 1), representing the average number of secondary cases caused by an undocumented case during an 385 average infectious period of 14 days. The 14 days was estimated by weighting the average interval 386 from infection to isolation for symptomatic individuals and the average interval from infection to 387 spontaneous recovery for asymptomatic individuals (Supplementary Information p16) . Second, the 388 number of undocumented cases was estimated based on the daily number of unknown-source and 389 known-source cases through the above linear relationships. Third, the overall number of secondary 390 cases over the next 14 days was obtained by multiplying R e with the number of undocumented cases. 391

Based on data from past outbreaks, we found that dividing this number by 2 gave a good fit for the 392 number of reported cases over the next 7 days ( Supplementary Information p16-17) . 393 394

We used the number of daily reported locally acquired cases as an indicator to inform the critical 396 timing for intervention commencement. Previous studies had reported that the turning point of the 397 epidemic would occur after a delay of approximately one week from the intervention 398 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 7, 2021. ; commencement 48-50 . At the same time, the number of daily reported cases would likely continue to 399 rise until R e was effectively reduced below one. The turning point marked the peak of the outbreak. 400

Therefore, for the time gap between intervention commencement and when R e fell below one, it 401 would be in the best interest for the stakeholders to confine the number of daily reported cases to a 402 manageable level (e.g. ≤10 cases/day) to avoid overloading its care capacity or substantially impact 403 on country's economic activities. We defined the number of reported cases that would trigger 404 intervention commencement to reduce R e to below one and maintain the average number of daily 405 reported cases over a 7-day period into interventions to be the critical timing for intervention 406 implementation.

We assumed that R e would decrease uniformly from its initial value to one after 7 days into the 409 interventions. We used an autoregressive approach to estimate the average number of reported cases 410 7 days into the intervention. First, we projected the average daily number of cases over the next 7 411 days using the number of reported locally acquired cases and R e on the day of intervention 412 commencement. We assumed that the average daily number of cases equals the number of cases on 413 the 4 th day; we then linearly interpolated the cases to obtain the number of reported cases one day 414 after intervention. We used a similar approach iteratively to estimate the number of reported cases 415 over the first 7 days after interventions. The critical timing was obtained by limiting the estimated 416 average daily number of cases over the next 7 days after interventions to an average of ≤10 cases/day. 417 418

To validate the reliability and generalisability of the model predictions, we compared the projected 420 number of cases over the next 7 days with the actual number of reported cases over a 7-day period Tables & Figures  446 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 7, 2021. ; CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 7, 2021. ; https://doi.org/10.1101/2021.07.06.21260055 doi: medRxiv preprint Fig. 3 Trajectories of changes of intervention, R e and the predicted outbreak severity for the past 459

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 7, 2021. ; https://doi.org/10.1101/2021.07.06.21260055 doi: medRxiv preprint . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 7, 2021. ; https://doi.org/10.1101/2021.07.06.21260055 doi: medRxiv preprint 

World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard

If the world fails to protect the economy, COVID-19 will damage 472 health not just now but also in the future

COVID-19 vaccine tracker

COVID-19 vaccine challenges: 476 what have we learned so far and what remains to be done? Health Policy

An early warning approach to monitor COVID-19 activity with multiple 479 digital traces in near real-time

Detection and quantification of SARS-CoV-2 RNA in wastewater and 481 treated effluents: surveillance of COVID-19 epidemic in the United Arab Emirates

Google and Harvard School of Public Health

Infectious Disease Dynamics Lab. COVID Scenario Pipeline

Institute for Data, Systems, and Society

Vaccination and non-491 pharmaceutical interventions for COVID-19: a mathematical modelling study

Role of masks, testing and contact tracing in preventing COVID-19 494 resurgences: a case study from New South Wales

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in 496

A very simple model to account for the rapid rise of the British variant of SARS-498

CoV-2 in several countries and the world

SARS-CoV-2 variants in Switzerland

Delta variant: What is happening with transmission, hospital admissions, and 504 restrictions?

Ministry of Health. COVID-19: Source of cases

Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine

Effectiveness of COVID-19 vaccines against hospital admission with the 556

Effectiveness of COVID-19 vaccines against the B.1.617.2 variant

Scotland: demographics, risk of hospital admission, and vaccine effectiveness

Multiparameter calibration of a natural history model of cervical cancer

Genetic algorithms for modelling and optimisation

Reproduction numbers and sub-threshold endemic equilibria 568 for compartmental models of disease transmission

Estimating the extent of true asymptomatic COVID-19 and its potential for community 571 transmission estimation of the effective reproductive number from disease outbreak data

On the definition and the computation of the 574 basic reproduction ratio R 0 in models for infectious diseases in heterogeneous populations

Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome 577 sequencing and agent-based modeling

Early analysis of the Australian COVID-19 epidemic

A Discrete-Event, Simulated Social Agent-Based Network 581

Transmission (DESSABNeT) model for communicable diseases: method and validation 582 using SARS-CoV-2 data in three large Australian cities

Non-compulsory measures sufficiently reduced human mobility in Tokyo 584 during the COVID-19 epidemic

Effectiveness of non-pharmaceutical interventions on COVID-19 transmission 586 in 190 countries from 23

Estimating worldwide effects of non-588 pharmaceutical interventions on COVID-19 incidence and population mobility patterns using 589 a multiple-event study

Effects of public health interventions on the epidemiological spread during 591 the first wave of the COVID-19 outbreak in Thailand

Effect of public health interventions on COVID-19 cases: an observational 593 study